Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OBA (Opioid-Based Anesthesia) refers to a specific anesthetic protocol used as the control arm in a clinical trial conducted by Attikon Hospital to evaluate postoperative pain management. This regimen consists of a combination of the intravenous sedative-hypnotic propofol and the synthetic opioids fentanyl and remifentanil. In this protocol, propofol is used for both induction and maintenance of anesthesia, while fentanyl is administered at induction and remifentanil is infused for maintenance. The protocol is designed to provide stable intraoperative anesthesia and analgesia through the activation of GABA-A receptors and mu-opioid receptors, respectively. It serves as the standard-of-care comparator against Opioid-Free Anesthesia (OFA) in patients undergoing transurethral urological surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propofol + fentanyl + remifentanil.